Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases

' To our knowledge, this is the first study to bridge this knowledge gap by presenting ' real-world ' data on the safety and efficacy of ICI on a national scale, ' wrote Monique K. van der Kooij, MD.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Hematology-Oncology News Source Type: news